However, prior to this announcement, Cencora's dividend was comfortably covered by both cash flow and earnings. This means that most of its earnings are being retained to grow the business.

Cencora's Q4 sales rose 14.7% to $79.1 billion, exceeding $77.65 billion consensus; adjusted EPS increased 16.8% to $3.34. The Retina Consultants of America deal will add nearly 300 retina ...

the benefits of the proposed transaction, future opportunities for Cencora and RCA and any other statements regarding Cencora’s or RCA’s future operations, financial or operating results ...

CONSHOHOCKEN, Pa., November 06, 2024--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America ("RCA"), a ...

If it is predictable over a long period, even low dividend yields can be attractive. However, prior to this announcement, Cencora's dividend was comfortably covered by both cash flow and earnings.

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. RCA is a management services organization that operates a network of retina ...

CONSHOHOCKEN, PA — Cencora, Inc. (NYSE: COR) has announced a definitive agreement to acquire Retina Consultants of America ...

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)-- Cencora, Inc. (NYSE: COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America (“RCA”), a leading ...

Such forward-looking statements may include, without limitation, statements about the proposed transaction with RCA, the expected timetable for completing the proposed transaction, the benefits of the ...

Cencora has a 52 week low of $184.00 and a 52 week high of $247.66. The firm’s 50-day simple moving average is $231.39 and its two-hundred day simple moving average is $230.60. 10 Stocks to Sell ...